Literature DB >> 9142672

HIV risk reduction and service delivery strategies in criminal justice settings.

J A Inciardi1.   

Abstract

Because of the HIV risk behaviors of substance abusers, particularly injection drug users and those who exchange sex for drugs, and the large numbers who are already infected with HIV or showing symptoms of AIDS, significant service delivery issues are associated with their criminal justice processing. Many strategies have been implemented in correctional settings in an effort to prevent and control the transmission of HIV. A number of these are for the purpose of lowering transmission risk in institutions, whereas others have been structured for the sake of offering prevention/intervention to inmates before they return to the free community. As such, prisons and jails represent opportune settings for HIV prevention and education. The most common HIV control/prevention/education strategies include mandatory testing of inmates for HIV, segregating infected inmates from the general prison population, establishing special health care units for HIV positive and AIDS symptomatic inmates, offering HIV prevention and risk reduction programs, and granting medical parole for the terminally ill. Because drug abuse treatment results in substantial declines in the use of heroin, cocaine, and other drugs, treatment per se can play a significant role in reducing the spread of HIV and AIDS among those coming to the attention of the criminal justice system. Most promising are continuous and integrated treatment services that are tied to the stages of correctional supervision: primary treatment while incarcerated; secondary treatment while on work release, halfway house or community supervision; and, tertiary treatment in ongoing aftercare.

Entities:  

Mesh:

Year:  1996        PMID: 9142672     DOI: 10.1016/s0740-5472(96)00117-1

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  9 in total

1.  Identifying infectious diseases in prisons: surveillance, protection, and intervention.

Authors:  M C White
Journal:  West J Med       Date:  1999-03

2.  HIV and AIDS risk behaviors among female jail detainees: implications for public health policy.

Authors:  Gary Michael McClelland; Linda A Teplin; Karen M Abram; Naomi Jacobs
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

3.  HIV and AIDS risk behaviors in juvenile detainees: implications for public health policy.

Authors:  Linda A Teplin; Amy A Mericle; Gary M McClelland; Karen M Abram
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

4.  Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.

Authors:  Parya Saberi; Nikolai H Caswell; Ross Jamison; Milton Estes; Jacqueline P Tulsky
Journal:  J Urban Health       Date:  2012-10       Impact factor: 3.671

5.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

Review 6.  HIV/AIDS behind bars: an avenue for culturally sensitive interventions.

Authors:  N I Osemene; E J Essien; I G Egbunike
Journal:  J Natl Med Assoc       Date:  2001-12       Impact factor: 1.798

7.  A descriptive profile of health problems, health services utilization, and HIV serostatus among incarcerated male drug abusers.

Authors:  Carl G Leukefeld; Michele Staton; Matthew L Hiller; T K Logan; Barbara Warner; Keena Shaw; Richard T Purvis
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

8.  Education, empowerment and community based structural reinforcement: an HIV prevention response to mass incarceration and removal.

Authors:  Jeffrey Draine; Laura McTighe; Philippe Bourgois
Journal:  Int J Law Psychiatry       Date:  2011-07-27

Review 9.  Group sex events amongst non-gay drug users: an understudied risk environment.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval
Journal:  Int J Drug Policy       Date:  2010-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.